What is the share price of Brooks Laboratories Ltd (BROOKS) today?
The share price of BROOKS as on 10th July 2025 is ₹148.67. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Brooks Laboratories Ltd (BROOKS) share?
The past returns of Brooks Laboratories Ltd (BROOKS) share are- Past 1 week: 6.06%
- Past 1 month: 13.19%
- Past 3 months: 20.09%
- Past 6 months: -18.34%
- Past 1 year: 71.91%
- Past 3 years: 78.69%
- Past 5 years: 411.40%
What are the peers or stocks similar to Brooks Laboratories Ltd (BROOKS)?
The peers or stocks similar to Brooks Laboratories Ltd (BROOKS) include:What is the market cap of Brooks Laboratories Ltd (BROOKS) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Brooks Laboratories Ltd (BROOKS) is ₹437.94 Cr as of 10th July 2025.What is the 52 week high and low of Brooks Laboratories Ltd (BROOKS) share?
The 52-week high of Brooks Laboratories Ltd (BROOKS) is ₹198.86 and the 52-week low is ₹82.What is the PE and PB ratio of Brooks Laboratories Ltd (BROOKS) stock?
The P/E (price-to-earnings) ratio of Brooks Laboratories Ltd (BROOKS) is -43.93. The P/B (price-to-book) ratio is 6.68.Which sector does Brooks Laboratories Ltd (BROOKS) belong to?
Brooks Laboratories Ltd (BROOKS) belongs to the Health Care sector & Labs & Life Sciences Services sub-sector.How to buy Brooks Laboratories Ltd (BROOKS) shares?
You can directly buy Brooks Laboratories Ltd (BROOKS) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Brooks Laboratories Ltd
BROOKS Share Price
148.670.00% (+0.00)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
BROOKS Stock Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
BROOKS Performance & Key Metrics
BROOKS Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -43.97 | 6.68 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.59 | 6.40 | 0.79% |
BROOKS Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
BROOKS Company Profile
Brooks Laboratories Ltd. is a Contract Manufacturing Company. The Company manufacturers molecules in Injectables and Clavulanic Acid range in Tablets and Dry Syrups.
DIVISLAB
PE Ratio
82.93
82.93
1Y Return
47.61%
47.61%
Buy Reco %
50.00
50.00
SYNGENE
PE Ratio
51.36
51.36
1Y Return
14.81%
14.81%
Buy Reco %
71.43
71.43
AARTIPHARM
PE Ratio
30.33
30.33
1Y Return
47.77%
47.77%
Buy Reco %
0.00
0.00
PE Ratio
1,232.49
1,232.49
1Y Return
52.01%
52.01%
Buy Reco %
0.00
0.00
VIMTALABS
PE Ratio
30.18
30.18
1Y Return
78.76%
78.76%
Buy Reco %
0.00
0.00
BROOKS Forecast
BROOKS Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
BROOKS
BROOKS
Income
Balance Sheet
Cash Flow
Annual Normal View
BROOKS Income Statement
BROOKS Income Statement
Annual Normal View
| Financial Year | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 77.99 | 91.98 | 63.77 | 80.45 | 83.44 | 83.47 | ||||||
Raw Materials | 51.77 | 66.28 | 47.45 | 56.59 | 90.60 | 90.63 | ||||||
| Power & Fuel Cost | 2.70 | 3.99 | 3.23 | 1.73 | ||||||||
| Employee Cost | 12.04 | 16.85 | 16.00 | 10.09 | ||||||||
| Selling & Administrative Expenses | 6.21 | 8.57 | 6.21 | 4.05 | ||||||||
| Operating & Other expenses | 4.01 | 9.75 | 20.04 | 24.93 | ||||||||
EBITDA | 1.26 | -13.46 | -29.16 | -16.94 | -7.16 | -7.16 | ||||||
| Depreciation/Amortization | 7.14 | 7.35 | 7.03 | 1.77 | 1.60 | 1.60 | ||||||
| PBIT | -5.88 | -20.81 | -36.19 | -18.71 | -8.76 | -8.76 | ||||||
| Interest & Other Items | 3.10 | 3.10 | 2.18 | 0.84 | 1.03 | 1.02 | ||||||
| PBT | -8.98 | -23.91 | -38.37 | -19.55 | -9.79 | -9.78 | ||||||
| Taxes & Other Items | 10.38 | -12.61 | -17.47 | 0.03 | 0.18 | 0.18 | ||||||
| Net Income | -19.36 | -11.30 | -20.90 | -19.58 | -9.97 | -9.96 | ||||||
| EPS | -7.76 | -4.53 | -8.38 | -7.65 | -373.00 | -3.79 | ||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
BROOKS Company Updates
BROOKS Stock Peers
BROOKS Past Performance & Peer Comparison
BROOKS Past Performance & Peer Comparison
Comparing 3 stocks from
Health CareLabs & Life Sciences Services
Compare valuation-basic on Screener
Health CareLabs & Life Sciences Services
Valuation
Technical
Forecast
Compare valuation-basic on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Brooks Laboratories Ltd | -43.93 | 6.68 | — |
| Divi's Laboratories Ltd | 82.93 | 13.39 | 0.44% |
| Syngene International Ltd | 51.36 | 5.39 | 0.20% |
| Aarti Pharmalabs Ltd | 30.33 | 4.70 | 0.55% |
BROOKS Stock Price Comparison
Compare BROOKS with any stock or ETFCompare BROOKS with any stock or ETF
BROOKS
BROOKS Holdings
BROOKS Shareholdings
BROOKS Promoter Holdings Trend
BROOKS Promoter Holdings Trend
BROOKS Institutional Holdings Trend
BROOKS Institutional Holdings Trend
Decreased Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has decreased by 2.17%
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
BROOKS Shareholding Pattern
BROOKS Shareholding Pattern
BROOKS Shareholding History
BROOKS Shareholding History
Foreign Institutions
Mutual Funds Invested in BROOKS
Mutual Funds Invested in BROOKS
No mutual funds holding trends are available
Top 1 Mutual Funds holding Brooks Laboratories Ltd
| Funds (Top 1) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 9.9181% | Percentage of the fund’s portfolio invested in the stock 3.24% | Change in the portfolio weight of the stock over the last 3 months 0.74% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 14/52 (-2) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing BROOKS stock
smallcases containing BROOKS stock
Looks like this stock is not in any smallcase yet.
BROOKS Events
BROOKS Events
BROOKS Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
BROOKS has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
BROOKS Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
BROOKS has not given any dividends in last 5 years
BROOKS Dividends
BROOKS Dividends
Hmm, looks like data is unavailable here. Please come back after some timeBROOKS Stock News & Opinions
BROOKS Stock News & Opinions
Articles & Videos
Earnings
Brooks Laboratories reports consolidated net loss of Rs 1.46 crore in the March 2025 quarter
Net Loss of Brooks Laboratories reported to Rs 1.46 crore in the quarter ended March 2025 as against net loss of Rs 9.61 crore during the previous quarter ended March 2024. Sales rose 31.60% to Rs 23.32 crore in the quarter ended March 2025 as against Rs 17.72 crore during the previous quarter ended March 2024. For the full year,net loss reported to Rs 9.97 crore in the year ended March 2025 as against net loss of Rs 19.59 crore during the previous year ended March 2024. Sales rose 3.86% to Rs 82.56 crore in the year ended March 2025 as against Rs 79.49 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales23.3217.72 32 82.5679.49 4 OPM %-5.36-53.78 --9.74-22.48 - PBDT-0.90-9.15 90 -8.19-17.79 54 PBT-1.28-9.61 87 -9.79-19.57 50 NP-1.46-9.61 85 -9.97-19.59 49 Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
Brooks Laboratories standalone net profit rises 356.67% in the March 2025 quarter
Net profit of Brooks Laboratories rose 356.67% to Rs 1.37 crore in the quarter ended March 2025 as against Rs 0.30 crore during the previous quarter ended March 2024. Sales rose 31.60% to Rs 23.32 crore in the quarter ended March 2025 as against Rs 17.72 crore during the previous quarter ended March 2024. For the full year,net profit rose 99.35% to Rs 3.05 crore in the year ended March 2025 as against Rs 1.53 crore during the previous year ended March 2024. Sales rose 3.86% to Rs 82.56 crore in the year ended March 2025 as against Rs 79.49 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales23.3217.72 32 82.5679.49 4 OPM %6.782.14 -6.034.09 - PBDT1.940.76 155 4.833.33 45 PBT1.550.30 417 3.231.56 107 NP1.370.30 357 3.051.53 99 Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Brooks Laboratories to table results
Brooks Laboratories will hold a meeting of the Board of Directors of the Company on 28 May 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
Brooks Laboratories reports consolidated net loss of Rs 4.57 crore in the December 2024 quarter
Net Loss of Brooks Laboratories reported to Rs 4.57 crore in the quarter ended December 2024 as against net loss of Rs 3.88 crore during the previous quarter ended December 2023. Sales rose 76.78% to Rs 38.45 crore in the quarter ended December 2024 as against Rs 21.75 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales38.4521.75 77 OPM %-8.89-15.49 - PBDT-3.76-3.42 -10 PBT-4.55-3.85 -18 NP-4.57-3.88 -18 Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Brooks Laboratories to declare Quarterly Results
Brooks Laboratories will hold a meeting of the Board of Directors of the Company on 13 February 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Brooks Laboratories EGM scheduled
Brooks Laboratories announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 11 January 2025.Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Brooks Laboratories to conduct board meeting
Brooks Laboratories will hold a meeting of the Board of Directors of the Company on 11 December 2024Powered by Capital Market - Live
7 months agoCapital Market - Live
Earnings
Brooks Laboratories reports consolidated net loss of Rs 3.96 crore in the September 2024 quarter
Net Loss of Brooks Laboratories reported to Rs 3.96 crore in the quarter ended September 2024 as against net loss of Rs 1.64 crore during the previous quarter ended September 2023. Sales declined 14.51% to Rs 20.79 crore in the quarter ended September 2024 as against Rs 24.32 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales20.7924.32 -15 OPM %-16.40-4.52 - PBDT-3.53-1.20 -194 PBT-3.96-1.64 -141 NP-3.96-1.64 -141 Powered by Capital Market - Live
8 months agoCapital Market - Live
Corporate
Brooks Laboratories schedules board meeting
Brooks Laboratories will hold a meeting of the Board of Directors of the Company on 9 November 2024Powered by Capital Market - Live
8 months agoCapital Market - Live
Corporate
Brooks Laboratories to conduct AGM
Brooks Laboratories announced that the 22th Annual General Meeting (AGM) of the company will be held on 19 September 2024.Powered by Capital Market - Live
10 months agoCapital Market - Live
In last 6 months, promoter holding in the company has decreased by 10.97%
Pledged promoter holdings is insignificant